Delivery Order SPE2DB22D2007-SPE2DB24FJ3NT

Award Date 6/21/24
Potential Completion Date 6/24/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,937.71 firm fixed price delivery order is for the supply of 4565425019 ALVIMOPAN 12 MG CAPSULE UD 30S, with an ultimate completion date of August 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $5,321.77, is for the delivery of 4564860016 - Alvimopan 12 mg Capsule UD 30s, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of June 11, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $19,979.49 firm fixed price delivery order is for the supply of 4,566,047,909 units of the medication Alvimopan 12 MG Capsule UD 30S. The contract has an ultimate completion date of October 9, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alvimopan 12 mg capsules and has a ceiling value of $9,615.12. It is a firm-fixed-price delivery order with a period of performance through May 14, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,080.46 firm fixed-price delivery order is for the provision of 4,564,898,629 units of the prescription medication Alvimopan 12 mg capsules. The award does not include a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568616987 - ALVIMOPAN 12 MG CAPSULE UD 30S, with a ceiling value of $16,222.90. The contract is a firm fixed-price delivery order, with a performance period ending on June 24, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,601,268 units of the pharmaceutical product Alvimopan 12 mg capsules. The total ceiling value of the contract is $47,144.31, with a performance period extending to June 23, 2025. The contract is not set aside and was awarded on an open competition basis....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of a variety of medical and pharmaceutical products. The contract, valued at $784,784.64, has a firm fixed price and an ultimate completion date of March 25, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of a variety of pharmaceutical products and medical supplies. The contract has a firm fixed price, with a ceiling value of $4,028.56, and a period of performance through May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a Delivery Order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a firm fixed price of $2,106.51 and a completion date of June 23, 2025. The contract provides for the supply of a range of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ3NT
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $4,632.28, is for the delivery of 4564965579 ALVIMOPAN 12 MG CAPSULE UD 30S. The contract, awarded by the Defense Logistics Agency (DLA), a defense agency, is a Delivery Order with a Firm Fixed Price pricing type. The contract has no set-aside designation and has an ultimate completion date of June 24, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, the company holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/20/24, 9:13 AM